Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia
Open Access
- 17 November 2011
- journal article
- clinical trial
- Published by American Society of Hematology in Blood
- Vol. 118 (20), 5664-5670
- https://doi.org/10.1182/blood-2011-07-368746
Abstract
Hydroxyurea has been shown to be efficacious for the treatment of sickle cell anemia (SCA), primarily through the induction of fetal hemoglobin (HbF). However, the exact mechanisms by which hydroxyurea can induce HbF remain incompletely defined, although direct transcriptional effects and altered cell cycle kinetics have been proposed. In this study, we investigated potential epigenetic and alternative molecular mechanisms of hydroxyurea-mediated HbF induction by examining methylation patterns within the Gγ-globin promoter and miRNA expression within primary CD71+ erythrocytes of patients with SCA, both at baseline before beginning hydroxyurea therapy and after reaching maximum tolerated dose (MTD). Using both cross-sectional analysis and paired-sample analysis, we found that the highly methylated Gγ-globin promoter was inversely correlated to baseline HbF levels, but only slightly altered by hydroxyurea treatment. Conversely, expression of several specific miRNAs was significantly increased after hydroxyurea treatment, and expression of miR-26b and miR-151-3p were both associated with HbF levels at MTD. The significant associations identified in these studies suggest that methylation may be important for regulation of baseline HbF, but not after hydroxyurea treatment, whereas changes in miRNA expression may be associated with hydroxyurea-mediated HbF induction. This study was registered at ClinicalTrials.gov (NCT00305175).Keywords
This publication has 47 references indexed in Scilit:
- Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)The Lancet, 2011
- MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferationMolecular Cancer, 2011
- MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13Proceedings of the National Academy of Sciences of the United States of America, 2011
- microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell diseaseBlood, 2010
- How I use hydroxyurea to treat young patients with sickle cell anemiaBlood, 2010
- The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐upAmerican Journal of Hematology, 2010
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cellsBlood, 2008
- Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobinBlood, 2008
- Developmental- and differentiation-specific patterns of human γ- and β-globin promoter DNA methylationBlood, 2007